Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics
Tucker Maxson, Douglas A. Mitchell
Tetrahedron (2015) Vol. 72, Iss. 25, pp. 3609-3624
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions
Gerard Clarke, Kiran V. Sandhu, Brendan T. Griffin, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 198-224
Open Access | Times Cited: 272
Something old, something new: revisiting natural products in antibiotic drug discovery
Gerard D. Wright
Canadian Journal of Microbiology (2014) Vol. 60, Iss. 3, pp. 147-154
Open Access | Times Cited: 271
High-Definition Medicine
Ali Torkamani, Kristian G. Andersen, Steven R. Steinhubl, et al.
Cell (2017) Vol. 170, Iss. 5, pp. 828-843
Open Access | Times Cited: 223
Narrow-spectrum antibacterial agents
Roberta J. Melander, Daniel V. Zurawski, Christian Melander
MedChemComm (2017) Vol. 9, Iss. 1, pp. 12-21
Open Access | Times Cited: 196
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward
Amila K. Nanayakkara, Helen W. Boucher, Vance G. Fowler, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 6, pp. 488-504
Open Access | Times Cited: 137
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
Janet M. Sasso, Rumiana Tenchov, Robert E. Bird, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 11, pp. 1951-2000
Open Access | Times Cited: 59
Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients
Kafayat Yusuf, Venkatesh Sampath, Shahid Umar
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3110-3110
Open Access | Times Cited: 55
Computational Methods for Strain-Level Microbial Detection in Colony and Metagenome Sequencing Data
Christine Anyansi, Timothy J. Straub, Abigail L. Manson, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 100
Antimicrobial and Antibiofilm Activity of Human Milk Oligosaccharides against Streptococcus agalactiae, Staphylococcus aureus, and Acinetobacter baumannii
Dorothy L. Ackerman, Kelly M. Craft, Ryan S. Doster, et al.
ACS Infectious Diseases (2017) Vol. 4, Iss. 3, pp. 315-324
Open Access | Times Cited: 89
Directed Evolution of Microbial Communities
Álvaro Sánchez, Jean C. C. Vila, Chang‐Yu Chang, et al.
Annual Review of Biophysics (2021) Vol. 50, Iss. 1, pp. 323-341
Open Access | Times Cited: 68
Smart dental materials for antimicrobial applications
Carolina Montoya, Lina Roldan, Michelle Yu, et al.
Bioactive Materials (2022) Vol. 24, pp. 1-19
Open Access | Times Cited: 68
Sulfaguanidine Hybrid with Some New Pyridine-2-One Derivatives: Design, Synthesis, and Antimicrobial Activity against Multidrug-Resistant Bacteria as Dual DNA Gyrase and DHFR Inhibitors
Ahmed Ragab, Sawsan A. Fouad, Ola A. Abu Ali, et al.
Antibiotics (2021) Vol. 10, Iss. 2, pp. 162-162
Open Access | Times Cited: 58
The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections
Marco Cavaco, Miguel A. R. B. Castanho, Vera Neves
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 51
Promysalin Elicits Species-Selective Inhibition of Pseudomonas aeruginosa by Targeting Succinate Dehydrogenase
Colleen E. Keohane, A. Duncan Steele, Christian Fetzer, et al.
Journal of the American Chemical Society (2018) Vol. 140, Iss. 5, pp. 1774-1782
Open Access | Times Cited: 75
Mother Knows Best: Deciphering the Antibacterial Properties of Human Milk Oligosaccharides
Kelly M. Craft, Steven D. Townsend
Accounts of Chemical Research (2019) Vol. 52, Iss. 3, pp. 760-768
Open Access | Times Cited: 65
Bacterial Cytological Profiling as a Tool To Study Mechanisms of Action of Antibiotics That Are Active against Acinetobacter baumannii
Htut Htut Htoo, Lauren Brumage, Vorrapon Chaikeeratisak, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 4
Open Access | Times Cited: 58
Development of a novel hybrid antimicrobial peptide for targeted killing of Pseudomonas aeruginosa
Hyun Kim, Ju Hye Jang, Sun Chang Kim, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111814-111814
Closed Access | Times Cited: 58
Linking microbial communities to ecosystem functions: what we can learn from genotype–phenotype mapping in organisms
Andrew H. Morris, Kyle Meyer, Brendan J. M. Bohannan
Philosophical Transactions of the Royal Society B Biological Sciences (2020) Vol. 375, Iss. 1798, pp. 20190244-20190244
Open Access | Times Cited: 51
Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections
Lai Jiang, Linyu Ding, Gang Liu
Theranostics (2023) Vol. 13, Iss. 5, pp. 1545-1570
Open Access | Times Cited: 22
Pathogen-associated gene discovery workflows for novel antivirulence therapeutic development
Wing Yin Venus Lau, Patrick K. Taylor, Fiona S. L. Brinkman, et al.
EBioMedicine (2023) Vol. 88, pp. 104429-104429
Open Access | Times Cited: 18
Sideromycins as Pathogen-Targeted Antibiotics
Timothy A. Wencewicz, Marvin J. Miller
Topics in medicinal chemistry (2017), pp. 151-183
Closed Access | Times Cited: 56
Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China
Hélio S. Sader, Glenn E. Dale, Paul R. Rhomberg, et al.
Antimicrobial Agents and Chemotherapy (2018) Vol. 62, Iss. 7
Open Access | Times Cited: 48
Mining Fatty Acid Biosynthesis for New Antimicrobials
Christopher D. Radka, Charles O. Rock
Annual Review of Microbiology (2022) Vol. 76, Iss. 1, pp. 281-304
Open Access | Times Cited: 28
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 5
Pediocin-Like Antimicrobial Peptides of Bacteria
Sergey V. Balandin, Elvira V. Sheremeteva, Tatiana V. Ovchinnikova
Biochemistry (Moscow) (2019) Vol. 84, Iss. 5, pp. 464-478
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top